MedTrace Logo

Mental Health Associations With Vitiligo

NCT04953338 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 36104

Last updated 2025-12-02

Study results available
· View outcomes & findings →

Summary

This cohort study is a large population-based study in the UK to determine the risks of comorbid mental health conditions (including depression, anxiety and other potential psychological complications of vitiligo) in adults with vitiligo compared to controls and to evaluate whether the relative risks may vary by different ethnicity.

Conditions

Interventions

OTHER

Exposure of mental health condtion of interest

Common mental health conditions consist of depressive episodes, recurrent depressive disorder and anxiety disorder.

Sponsors & Collaborators

  • Pfizer

    collaborator INDUSTRY

  • Momentum Data

    lead INDUSTRY

Principal Investigators

  • Andrew McGovern, MD · Momentum Data Ltd

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-06-18
Primary Completion
2022-08-30
Completion
2022-10-21

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04953338 on ClinicalTrials.gov